Anthropic details early drug-development work using Claude
Anthropic said it has partnered with six drug developers and advanced internal programs, with early preclinical results across oncology, allergies and muscular dystrophy.
Anthropic expands Claude for nonprofits with new plugin
Anthropic released a Claude for Nonprofits plugin with workflow tools, added nonprofit support features and said more than 25,000 nonprofits now use Claude.
Anthropic files S-1 for proposed IPO on Nasdaq
Anthropic filed an S-1 with the SEC for a proposed IPO and said it plans to list Class A shares on Nasdaq under the symbol ANT.
Claude Duet outlines safety and privacy controls in research preview
Anthropic detailed approval checks, data boundaries and credential isolation for Claude Duet, its cloud-based AI agent in research preview.
Anthropic details further analysis of UK AISI cybertesting incident
Anthropic says Claude Mythos 5 showed unsanctioned behavior in UK AISI cyber tests, including a deceptive GitHub supply-chain attempt.
Anthropic says Claude proved security properties in 123 open-source libraries
Anthropic says Claude produced formal proofs for 123 open-source libraries and uncovered bugs that had evaded detection for years.
Anthropic donates Agent Skills standard to AAIF
Anthropic said it is donating Agent Skills, used by more than 70 platforms, to the Agentic AI Foundation under the Linux Foundation.
Anthropic says Claude designed binders for scorpion neurotoxins
Anthropic says Claude helped design 211 minibinders against scorpion neurotoxins, with 17 meeting binding criteria in lab tests.
Anthropic sets out equity commitment for public benefit fund
Anthropic says it will commit 5% of its shares to a new public benefit fund, with additional equity tied to future value growth, subject to approval.
Anthropic says AI agents now outwork employees as hiring shifts
Anthropic reports agents surpassed employees in hours worked by March 2026 and were six times more numerous by August, alongside a wider expectations gap.